Cancer Clinical Trials - survey evaluating patient participation and
attitude in an Oncology Center
Radiother Oncol
2018
127
S50-S50
Patients with 18F-FDG PET-positive hepatocellular carcinoma and elevated
values of alpha-fetoprotein and C-reactive protein have an extraordinary
high risk of tumor recurrence following liver transplantation
J Hepatol
2018
68
S382-S383
Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study.
Ann Surg Oncol
2018
25
5
1440-1447
The impact of surgically placed, intraperitoneal drainage on morbidity and mortality after pancreas resection- A systematic review & meta-analysis.
Pancreatology
2018
18
3
334-345
Comparison of neoadjuvant chemoradiation with carboplatin/paclitaxel or
CDDP/5-FU for esophageal SCC
Radiother Oncol
2018
127
S768-S769
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.
Int J Epidemiol
2018
47
2
473-483
Meta-analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma.
BJS Open
2018
2
2
52-61
Risk of malignancy in resected pancreatic mucinous cystic neoplasms.
Br J Surg
2018
105
4
439-446
Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
PLoS ONE
2018
13
3
Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Mol Carcinog
2018
57
2
201-215